Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 78,816 | 64,344 | 25,321 | 23,879 | -5,201 |
| Depreciation Amortization | 27,662 | 21,208 | 14,103 | 7,197 | 25,818 |
| Income taxes - deferred | -5,464 | -1,275 | -1,274 | -1,274 | N/A |
| Accounts receivable | -33,144 | -55,420 | -9,742 | -10,086 | N/A |
| Accounts payable and accrued liabilities | 1,176 | 130 | 3,419 | 3,402 | N/A |
| Other Working Capital | 35,893 | 326 | -2,814 | -4,729 | 2,290 |
| Other Operating Activity | 47,248 | 43,443 | -7,685 | -8,676 | 1,208 |
| Operating Cash Flow | $152,187 | $72,756 | $21,328 | $9,713 | $24,115 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 9,092 | 17,941 | 28,032 | 31,091 | -17,148 |
| Net Acquisitions | -3,024 | -3,024 | -3,024 | -3,024 | 0 |
| Investing Cash Flow | $6,068 | $14,917 | $25,008 | $28,067 | $-17,148 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 609,000 | 15,000 | 15,000 | 15,000 | N/A |
| Debt Repayment | -412,076 | -1,898 | -1,327 | -661 | N/A |
| Common Stock Issued | 1,758,932 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | -1,467,122 | N/A | N/A | N/A | N/A |
| Dividend Paid | -97,051 | N/A | N/A | N/A | 0 |
| Other Financing Activity | -338,471 | -562 | -190 | 0 | -4,167 |
| Financing Cash Flow | $53,212 | $12,540 | $13,483 | $14,339 | $-4,167 |
| Exchange Rate Effect | 17 | -31 | -61 | -72 | 34 |
| Beginning Cash Position | 24,700 | 24,700 | 24,700 | 24,700 | 21,866 |
| End Cash Position | 236,184 | 124,882 | 84,458 | 76,747 | 24,700 |
| Net Cash Flow | $211,484 | $100,182 | $59,758 | $52,047 | $2,834 |
| Free Cash Flow | |||||
| Operating Cash Flow | 152,187 | 72,756 | 21,328 | 9,713 | 24,115 |
| Capital Expenditure | -25,408 | -16,559 | -6,468 | -3,409 | N/A |
| Free Cash Flow | 126,779 | 56,197 | 14,860 | 6,304 | 24,115 |